That, in itself, is a significant stride forward in the care of Ehlers-Danlos Syndrome.
Individual experience varies based on the specific medication ( semaglutide versus tirzepatide versus retatrutide ), your dose, your baseline gut health, your diet, and how consistently you apply the relief strategies
Understanding the biology and the human clinical trial data helps you decide whether a trial makes sense for you
) Weight-related diagnoses (Blood pressure, prediabetes, type 2 diabetes, lipids, sleep apnea, fatty liver disease, cardiovascular history) Prior weight-loss attempts (your lifestyle, nutrition, medications, structured interventions) Relevant medical history (pancreatitis, gallbladder disease, severe GI motility disorders, personal or family history of medullary thyroid cancer or MEN2, pregnancy, or plans for pregnancy) Why it works: GLP-1 medications are indicated for adults with a BMI 30, or a BMI 27 with at least one weight-related condition